Best Lymph Node Biopsy or Excision Doctors in Astoria, NY

We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

I am a surgeon who specializes in nerve-sparing radical prostatectomy for the treatment of prostate cancer, and 'salvage' radical prostatectomy in patients with prostate cancer in whom radiation therapy has failed. My clinical research focuses on improving outcomes (such as cancer control, urinary continence, and sexual function) following surgery for prostate cancer. Together with my colleagues in medical oncology and radiation oncology, we attempt to tailor therapy more accurately to each individual's cancer in order to control cancer spread and decrease treatment-related side effects.

Click here to view New York Times article on Dr. Michelassi's strictureplasty for crohns disease.

Dr. Hiroo Takayama is Vice Chair of Cardiac, Vascular, and Thoracic Surgery at NewYork-Presbyterian/Columbia University Irving Medical Center. He has more than 20 years of experience in treating patients with heart and vascular problems. As the co-Director of the Aortic Center at NYP/Columbia, Dr. Takayama has contributed to the care of over 4,000 patients by performing a variety of aortic and cardiac surgical procedures, approximately 300-350 operations every year. Dr. Takayama is internationally recognized for his work on complex aortic surgery (minimally invasive aortic surgery, valve-sparing aortic root replacement, aortic valve repair, aortic arch and thoracoabdominal aneurysm repair), hybrid aortic surgery (thoracic endovascular aneurysm repair), myectomy for obstructive hypertrophic cardiomyopathy, and heart failure surgery. He is a leader in outcome research in aortic diseases and heart failure. He has published more than 300-350 manuscripts in prestigious, peer-reviewed journals and has authored numerous book chapters about heart disease. Dr. Takayama attended University of Tokyo for Medical School, did his internship at University of Tokyo, general surgery residency in University of Washington Medical Center, and cardio-thoracic surgery fellowship in New-York Presbyterian/Columbia University Medical Center.

Thomas J. Fahey, III, MD is the Vice Chairman of the Department of Surgery, Chief of Endocrine Surgery, Director of the Endocrine Oncology Program, and Professor of Surgery at Weill Cornell Medical College. He is an Attending Surgeon at New York Presbyterian-Weill Cornell Medical Center. Dr. Fahey is an internationally-recognized expert in minimally-invasive endocrine surgery procedures. For more information about Dr. Fahey and endocrine surgery services click here. Dr. Fahey was named by both Castle Connolly and U.S. News & World Report as one of "America's Top Doctors" every year since 2011, and has been consistently recognized by New York Magazine as one of New York's "Best Doctors," and as a "New York SuperDoctor," an honor accorded just 5% of all New York physicians.

Dr. Ninan Koshy, MB Bs is a General Surgery Specialist who practices in New York, NY. He is 59 years old and has been practicing for 36 years. Dr. Ninan Koshy, MB Bs is affiliated with Mount Sinai Morningside.

David Otterburn, MD, FACS, is a Professor of Surgery in the Division of Plastic and Reconstructive Surgery in the Department of Surgery at Weill Cornell Medical College. He is an Attending Surgeon at NewYork-Presbyterian Hospital/Weill Cornell Medical Center and is the Program Director for the Weill Cornell Medicine and Columbia University Medical Center Combined Plastic Surgery Residency Program of NYPH.Dr Otterburn is the Director of Breast Reconstruction at Weill Cornell Medicine and started the DIEP reconstruction program at Weill Cornell in 2011 and has performed over 1000 DIEP reconstructions. He has pioneered techniques to maximize the safety and efficacy of this surgery which include methods to increase aesthetic outcome, increase sensory return, improve anesthesia delivery while decreasing narcotic use after surgery and decrease overall complications during this complex surgery. He has performed innervation of DIEP flaps since 2011 and was an early adaptor in the use of nerve grafts in breast reconstruction.He has also pioneered the drainless approach to breast implant-based breast reconstruction as he recognized external drains to be one of the greatest concerns for our patients. In doing so he has significantly lowered the complication rates and postoperative pain levels for these procedures. He also uses indwelling antibiotic delivery systems which significantly decrease the risk of infection following mastectomies. He is a requested speaker at both national and international meetings on these and other topics and has an active laboratory which has published over 100 papers on these and other subjects. He has been awarded several grants for his research including from the NIH and has won awards both nationally and internationally, at many of the major plastic surgery meetings.Dr. Otterburn completed board certification in both Plastic and General Surgery. He has additional training and specialization in microvascular surgery for complex reconstructions throughout the body, utilizing 3-D imaging and other state-of-the-art technologies to obtain optimal outcomes. A special focus includes innervated microvascular breast reconstruction with perforator flaps from the abdomen (DIEP), buttocks (SGAP, IGAP) and thigh (PAP) and studying sensory return in the breast with nerve grafting techniques in both implant and flap reconstructions. He also performs soft tissue reconstruction with osteointegrated implant reconstruction for amputees and targeted muscle reinnervation and regenerative peripheral nerve interfaces to decrease nerve pain. His surgical expertise also includes oculoplastic reconstruction and reconstruction following Mohs surgery.Dr. Otterburn offers his patients aesthetic surgery of the face and body. This included botox, fillers and more invasive surgeries such as face lifts, neck lifts and blepharoplasties. He performs body contouring including liposuction, abdominoplasties, circumferential body lifts, thigh lifts, breast augmentations and breast lifts. His aesthetic goals are tailored to the individual patient, but is looking to provide you with a natural, seamless aesthetic result.

I am a board-certified general surgeon and surgical oncologist with a clinical expertise in melanoma and soft tissue sarcoma. I work closely with the patient and the comprehensive team of physicians to customize treatment plans for each individual. In my research, I am investigating new ways to allow the immune system to fight cancer. I am also involved in clinical trials aimed at defining the role of current therapies and improving outcomes through novel new treatments. I am fluent in both Spanish and English.

I am a surgical oncologist whose primary area of clinical and research interest is melanoma. In 1991, I introduced lymph-node mapping and sentinel lymph-node biopsy for melanoma and other selected skin cancers. Together, these procedures can determine during surgery whether a tumor has spread to surrounding lymph nodes. Using lymph node mapping, we can pinpoint the precise lymph node into which a nearby tumor is likely to travel first (called the sentinel node). If a biopsy of the sentinel node indicates cancer spread, the surrounding lymph nodes are removed. But if there is no evidence of cancer in the sentinel node, patients are spared from additional lymph node surgery. My research has focused primarily on detecting and defining the clinical significance of individual melanoma cells in the sentinel lymph nodes, blood, and bone marrow of melanoma patients, with the goal of identifying patients at highest risk of cancer recurrence following surgery to remove a melanoma. I served as Chief of the Gastric and Mixed Tumor Service in MSKCC's Department of Surgery from 1997 until October 2003. This service focuses primarily on the surgical management of less common malignancies, including melanoma, sarcoma, gastric cancer, and pancreatic cancer, and also provides surgical support for the Lymphoma Service. I currently serve as a co-leader of the MSKCC Melanoma Disease Management Team -- a multidisciplinary team of surgeons, medical oncologists, pathologists, and other medical professionals who specialize in the diagnosis and treatment of melanoma. On a national and international level, I am involved in advancing new ways to diagnose and treat melanoma as a member of the American Joint Commission on Cancer Melanoma Staging Committee, the National Comprehensive Cancer Network Melanoma Advisory Group, the American College of Surgeons Commission on Cancer Melanoma Working Group, the American College of Surgeons Oncology Group's Melanoma Working Group, and the World Health Organization Melanoma Committee. In addition to my interest in melanoma, I also have an expertise in the treatment of gastric cancer. I served on the program committee of the International Gastric Cancer National Meeting in 2001. And in 2002, I was co-leader of the Gastric Cancer Working Group of the National Cancer Institute's Stomach Cancer Progress Review Group. I am currently the co-principal investigator of two gastric cancer studies at MSKCC. The first evaluates the effectiveness of chemotherapy prior to surgery in high-risk gastric cancer patients, and the second is a 'Quality of Life Assessment' of gastric cancer patients. I am also an active member of the American College of Surgeons Oncology Group Upper GI Cancer Working Group. MSKCC plays a key role in training oncology doctors, and I have had a long-standing interest in the training of surgical oncology fellows. I served as the Director of Surgical Education for the Surgical Oncology Fellowship Training Program at MSKCC from 1991 to 1997, and I was Director of the Society of Surgical Oncology Training Committee, where I oversaw the administration of all surgical oncology fellowships across the nation from 1994 to 1999. As part of my interest in spreading information we have learned about cancer at MSKCC, I have lectured extensively, both nationally and internationally, and authored a number of manuscripts and reviews on various surgical oncology topics. You can view a complete listing of my publications in PubMed by clicking on the PubMed icon to the right.

Dr. Elisa Port, MD is a General Surgery Specialist who practices in New York, NY. She is 62 years old. Dr. Elisa Port, MD is affiliated with Mount Sinai Morningside.

Dr. Raymond Chai, MD is an Otolaryngology (Ear, Nose /amp Throat) Specialist who practices in New York, NY. He is 45 years old and has been practicing for 18 years. Dr. Raymond Chai, MD is affiliated with Mount Sinai Morningside.

Dr. Christina Weltz, MD is a General Surgery Specialist who practices in New York, NY. She is 65 years old and has been practicing for 37 years. Dr. Christina Weltz, MD is affiliated with Mount Sinai Morningside.

I am a head and neck surgeon who has served on the faculty at Memorial Sloan-Kettering Cancer Center for more than a decade. I have a particular expertise and interest in the surgical removal of thyroid cancer, nodal metastases from thyroid cancer, and recurrent thyroid cancer. I also have a strong interest in treating oral cancer, parotid tumors, melanoma, sinus cancers, and parathyroid adenomas.

Urologic oncology is a multidisciplinary field that incorporates innovative surgical technology, systemic treatments such as chemotherapy as well as a focused research effort. As a Professor of Urology and the Clinical Director of Urologic Oncology I continually interact with colleagues in areas of medical oncology, radiation oncology, pathology among others in order to provide the most comprehensive and innovative care for our patients with prostate, bladder, kidney and testicular cancer. Advances in robotic technology along with scientific progress in our precision medicine program have allowed us to direct therapy in unprecedented ways. As a leader in this area I look forward to continued advances in this exciting and challenging field.

When deciding how to treat your breast cancer, it's important to understand all of your surgical options. Dr. Rache Simmons is a certified Hidden Scar Breast Surgeon and aHidden Scar Center of Excellence. Learn more about how this remarkable surgical procedure can help preserve a natural-looking breast HERE, or call her office to learn more.

My surgical practice and clinical research focus entirely on the treatment of breast cancer. My research interests have included patterns of loco-regional spread, long-term outcomes of breast cancer surgery, the impact of screening mammography and, most recently, sentinel lymph node biopsy. This procedure involves removing the first few lymph nodes draining from the breast ('sentinel nodes'), and checking for the presence of cancer. If the sentinel nodes are cancer free, then the remaining nodes don't need to be removed and the side effects of the surgery are minimized. I am currently the principal investigator of MSKCC's sentinel-node biopsy program, which has the world's largest experience with this exciting new operation. My colleagues and I continue to study and refine the procedure. We have presented and published our work worldwide and have taught the procedure to hundreds of practicing surgeons and trainees. I lecture widely and am the editor of a new multi-author textbook on sentinel-node biopsy.

PLEASE EXPECT A PHONE CALL FROM THE PRACTICE TO CONFIRM APPOINTMENT REQUESTED. Ashutosh Tewari is an accomplished and dedicated urologist treating his patients in New York City. Dr. Tewari is certified by the American Board of Urology and a member of the American Urological Association New York, the Society of Urologic Oncology, the Society of Laparoscopic Surgeons, the Society of Robotic Surgery, and the New York Academy of Medicine. He is currently serving as a professor and chair in the department of urology at the Mount Sinai Hospital. Dr. Tewari attended the Ganesh Shankar Vidyarthi Memorial Medical College in his native India. He also completed his surgical residency at this institution. Dr. Tewari relocated to the Henry Ford Hospital to complete his urology residency. Dr. Tewari completed three urology oncology fellowships at the University of California San Francisco, the Henry Ford Hospital, and the University of Florida. In addition to these extensive research opportunities, Dr. Tewari completed a transplant fellowship at the University of Liverpool. Dr. Tewari is a prostate cancer specialist, with clinical expertise with laparoscopy, prostate biopsy, prostate-specific antigen (PSA) testing, prostatectomy, robot-assisted urologic procedures, as well as robotic prostate surgery.